Clinical trial · Observational
Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk
An Observational, Retrospective Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk Through Gene Sequencing
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
An observational, Other Designs (OD) post-marketing, multicenter study, which will obtain retrospective data from male patients diagnosed with invasive breast cancer between 2000 and 2019 in the medical oncology departments of hospitals that are associated with Spanish Breast Cancer Research Group (GEICAM) (using information obtained from patient medical histories).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer, Male | Male Breast Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Male breast cancer
- description
- The study target population is all cases of male breast cancer (MBC), diagnosed with invasive breast cancer between the years 2000 and 2019, and treated in the Medical Oncology Departments of participating sites.
Primary outcomes (26)
- measure
- General condition: Age
- timeFrame
- From date of patient breast cancer diagnosis until 2019.
- description
- General condition age will be recorded.
- measure
- General condition: performance status at diagnosis
- timeFrame
- From date of patient breast cancer diagnosis until 2019.
- description
- Performance status by Eastern Cooperative Oncology Group (ECOG) Scale
- measure
- General condition and history: substance abuse
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male patients diagnosed with primary invasive breast carcinoma between the years 2000-2019, and who have been treated and/or followed up in the Medical Oncology Departments of participating sites. * The enrollment of patients who died is allowed. Exclusion Criteria: * Male patients who do not wish to participate in the study for any reason.
References
Publications (0)
Data not yet available